Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met plus Advanced Non-Small Cell Lung Cancer: Stage 2

Goldman, J.Moiseenko, F.Cicin, I.Horinouchi, H.Filippova, E.Bar, J.Lu, S.2024-06-122024-06-1220211556-08641556-1380https://hdl.handle.net/20.500.14551/18163[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessAdvanced Non-Small Cell Lung CancerTumor Biology - Immunoconjugates (Non-IO)Developmental Therapeutics-Molecularly Targeted AgentsTelisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met plus Advanced Non-Small Cell Lung Cancer: Stage 2Conference Object1610S1097S1097Q1WOS:000709606500495